The Nature Communications study profiled proteins and RNA in single oocytes from humans and mice and found age-linked molecular changes that transcript data alone would miss. The lactate transporter MCT4 emerged as a notable marker, and experimental manipulations in model systems suggest altered lactate export may actively contribute to oocyte aging. While some interventions improved egg-quality measures in models, these results do not yet translate into a human treatment and require much more research.
Lactate Transporter MCT4 Linked to Age-Related Decline in Egg Quality, Study Finds

Age-related fertility decline is usually explained as a reduction in the number and quality of eggs over time, but the cellular causes of that loss of quality remain incompletely understood. A new study published in Nature Communications identifies changes in lactate metabolism — and specifically the lactate transporter MCT4 — as a compelling molecular clue to why some oocytes (egg cells) become more vulnerable with age.
What the Researchers Did
The team profiled both proteins and RNA from individual oocytes collected from humans and mice at different developmental stages. By looking at protein abundance as well as gene-expression (RNA) levels in the same single cells, the researchers obtained a more complete picture of molecular changes that occur with aging.
Key Findings
Researchers found that protein-level changes did not always mirror RNA-level changes, meaning transcript data alone can miss important aspects of cellular aging. Among several altered molecules, the monocarboxylate transporter MCT4 — which helps export lactate from cells — stood out as a consistent difference between younger and older oocytes.
Follow-up laboratory and animal experiments suggested this was not merely a bystander change: experimentally increasing features that mimicked the aged lactate-handling state produced defects associated with oocyte aging, while inhibiting MCT4 improved several measures of egg quality in model systems.
Why This Matters
Lactate is a normal metabolite in cellular energy metabolism, and balanced lactate transport is important for cellular function. The study raises the possibility that altered lactate export via MCT4 contributes directly to age-related oocyte decline rather than simply reflecting it. If confirmed, MCT4 could become a useful research marker or therapeutic target for preserving egg quality.
Limitations And Next Steps
Important caveats remain. While the molecular survey included human oocytes, most functional intervention work was performed in experimental models (including mouse oocytes and lab systems). These models are essential for mechanism work but do not prove that blocking MCT4 will restore fertility in women. Extensive additional research is needed to assess safety, efficacy, and downstream effects on fertilization, embryo development, pregnancy, and long-term outcomes before any clinical application could be considered.
Takeaway
The study adds a precise metabolic angle to our understanding of egg aging: changes in protein composition and lactate handling — notably involving MCT4 — may help explain why egg quality deteriorates with age. For now, MCT4 is an intriguing research target rather than an available treatment.
Image Credit: Gorodenkoff via shutterstock
Question for readers: If scientists could identify which eggs are aging faster at a cellular level, would that information change how women approach fertility planning?
Help us improve.



























